RNAi Therapies: Drugging the Undruggable

Sherry Y. Wu, Gabriel Lopez‐Berestein, George A. Călin, Anil K. Sood

Science Translational Medicine · 2014 · 267 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

RNA interference (RNAi) therapy is a rapidly emerging platform for personalized cancer treatment. Recent advances in small interfering RNA delivery and target selection provide unprecedented opportunities for clinical translation. Here, we discuss these advances and present strategies for making RNAi-based therapy a viable part of cancer management.

References

24